Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Is team science productive?

19.10.2010
Penn study measures the collaborative nature of translational medicine

Taking a cue from the world of business-performance experts and baseball talent scouts, Penn Medicine translational medicine researchers are among the first to find a way to measure the productivity of collaborations in a young, emerging institute. They published their findings the most recent issue of Science Translational Medicine.

While metrics exist to measure the contributions of individual scientists, judging the effectiveness of team science has been more challenging. Reasoning that team science produces papers and grants, first author postdoctoral fellow Michael Hughes, PhD, (now at Yale University) and colleagues measured these endpoints and analyzed them over time using network analysis, which examines a social structure made up of individuals connected by a common interdependency.

Using the numbers of publications and grants as their raw data, researchers from Penn's Institute for Translational Medicine and Therapeutics (ITMAT) measured how their productivity changed with increasing collaborations over the last five years.

... more about:
»ITMAT »Medicine »health services

"We're applying quantitative methods to evaluate the collaborative nature of academic science and medicine," says senior author John Hogenesch, PhD, associate professor of Pharmacology in the University of Pennsylvania School of Medicine. Hogenesch is also an ITMAT member and interim director of the Penn Center for Bioinformatics.

They found that the number of collaborative papers for ITMAT members doubled since 2006. They also found that researchers were more likely to collaborate within their own departments and institutions than between them. "While understandable, if the purpose of an institute is to facilitate cross-disciplinary interactions, then encouraging people to collaborate across departments and institutes is critical," says Hogenesch.

The authors concluded that studies such as these could help inform decisions about which institutes, centers, or departments are most likely to facilitate collaboration, and learn how they're doing it. This will point the way to ideas to increase cross-discipline collaborations such as trans-center grants to facilitate collaborations between departments.

"The most challenging aspect of the study was acquiring the data. At this point, we've analyzed PubMed and research grants and only for ITMAT. Ideally, we would be able to compare these metrics to those from other similar institutes including more data sources. Also, as time goes by, having downstream measures of this productivity such as literature citations and investigational new drug applications will point the way towards learning the operational rules of translational science," says Hogenesch.

Inspired by America's Pastime

First author Hughes is a baseball fan, and he realized that professional baseball has kept detailed statistics on the outcomes of every at-bat in every game for the last 100-plus years. These data provide a wealth of information to quantitatively address the traits that predict a successful baseball career, and the types and combinations of players needed to win games. By quantitatively and objectively studying performance, baseball analysts have been able to identify and exploit inefficiencies in the labor market -- highly skilled players were sometimes under-valued because of widely-held, but incorrect, assumptions. "If they're measuring performance quantitatively in baseball, shouldn't we do the same for science?," asks Hughes.

But how do investigators evaluate their performance quantitatively -- especially the scientific output of an institution comprising hundreds of active researchers, let alone comparing performance among centers and institutes with similar missions at different universities. Using ITMAT's roster of members over time, the team used network dynamics as a first step towards measuring scientific performance of cross-disciplinary institutes and centers.

ITMAT was founded in 2004 as the world's first translational medicine institute, and as of January 2009, included over 500 active investigators spanning four institutions and dozens of academic departments. "We reasoned that ITMAT's productivity could be partly measured by how it facilitates collaborations between its members," says Hogenesch.

To collect data, the team generated special data-mining programs to automatically extract publication information from PubMed. In addition, they analyzed grant proposals submitted by ITMAT faculty during the last five years and additional data from NIH Reporter. From this they quantified the number of papers and grants by ITMAT investigators over time, and how these collaborative interactions changed over time.

ITMAT's overall size and complexity grew significantly since its inception. Not only has the total number of investigators actively collaborating within ITMAT increased during this time, the average investigator has been collaborating more.

"This finding was not surprising since as the size of the network grows, the probability that two investigators would interact to co-publish papers or co-submit grants grows," explains Hogenesch. "In network-speak, the number of edges – co-published papers and grants - per node – two or more investigators - grew nearly twice as fast during the past five years, as the growth of ITMAT's membership has grown, suggesting that ITMAT's expansion increased the number of collaborations. What's more, the percentage of ITMAT investigators actively collaborating within ITMAT grew every year, with nearly two-thirds actively engaged in collaborations in 2009."

This work was supported by ITMAT through a grant from the National Center for Research Resources. John Peeler, MA, was also an author on the paper.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $3.6 billion enterprise.

Penn's School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools, and is consistently among the nation's top recipients of funding from the National Institutes of Health, with $367.2 million awarded in the 2008 fiscal year.

Penn Medicine's patient care facilities include:

The Hospital of the University of Pennsylvania – the nation's first teaching hospital, recognized as one of the nation's top 10 hospitals by U.S. News & World Report.

Penn Presbyterian Medical Center – named one of the top 100 hospitals for cardiovascular care by Thomson Reuters for six years.

Pennsylvania Hospital – the nation's first hospital, founded in 1751, nationally recognized for excellence in orthopaedics, obstetrics & gynecology, and psychiatry & behavioral health.

Additional patient care facilities and services include Penn Medicine at Rittenhouse, a Philadelphia campus offering inpatient rehabilitation and outpatient care in many specialties; as well as a primary care provider network; a faculty practice plan; home care and hospice services; and several multispecialty outpatient facilities across the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2009, Penn Medicine provided $733.5 million to benefit our community.

Karen Kreeger | EurekAlert!
Further information:
http://www.uphs.upenn.edu

Further reports about: ITMAT Medicine health services

More articles from Studies and Analyses:

nachricht Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland

nachricht Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>